Get started
Author

Beatriz Seoane

Observed names: B Seoane, B Seoane Nuñez, B. Seoane, Beatriz Seoane Nuñez, Beatriz Seoane Núñez, Seoane, Beatriz
OpenAlex ID: A5063650460
Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants
2023 · William J. Muller, Shabir A. Madhi, et al. · New England Journal of Medicine · 255
Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants
2023 · Deidre Wilkins, Yuan Yuan, et al. · Nature Medicine · 140
PDF
Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD
2010 · François Maltais, Bartolome Celli, et al. · Respiratory Medicine · 101
PDF
Efficacy and safety of aclidinium/formoterolversussalmeterol/fluticasone: a phase 3 COPD study
2016 · Claus Vogelmeier, Pier Luigi Paggiaro, et al. · European Respiratory Journal · 100
Preference, satisfaction and errors with two dry powder inhalers in patients with COPD
2013 · Job van der Palen, Thomas Ginko, et al. · Expert Opinion on Drug Delivery · 64
Infants Receiving a Single Dose of Nirsevimab to Prevent RSV Do Not Have Evidence of Enhanced Disease in Their Second RSV Season
2024 · Ron Dagan, Laura L Hammitt, et al. · Journal of the Pediatric Infectious Diseases Society · 56
PDF
A randomised, placebo- and active-controlled dose-finding study of aclidinium bromide administered twice a day in COPD patients
2012 · D. Singh, H. Magnussen, et al. · Pulmonary Pharmacology & Therapeutics · 38
Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study
2015 · Sergi Pascual, Jan Feimer, et al. · npj Primary Care Respiratory Medicine · 33
PDF
First‐in‐human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of abediterol (LAS100977), a novel long‐acting Β2‐agonist
2014 · Wolfgang Timmer, Eric Massana, et al. · The Journal of Clinical Pharmacology · 20
Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
2016 · Lorcan McGarvey, Alyn H Morice, et al. · BMJ Open Respiratory Research · 19
PDF
Navafenterol (AZD8871) in patients with COPD: a randomized, double-blind, phase I study evaluating safety and pharmacodynamics of single doses of this novel, inhaled, long-acting, dual-pharmacology bronchodilator
2020 · Dave Singh, Victor Balaguer, et al. · Respiratory Research · 14
PDF
Abediterol, a novel long-acting β2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD
2016 · Jutta Beier, Helena Pujol, et al. · BMC Pulmonary Medicine · 14
PDF
A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study
2014 · Dave Singh, Helena Pujol, et al. · BMC Pulmonary Medicine · 14
PDF
Abediterol (LAS100977), a novel long-acting β2-agonist: Efficacy, safety and tolerability in persistent asthma
2014 · J. Beier, R. Fuhr, et al. · Respiratory Medicine · 14
PDF
The Effect of Aclidinium on Symptoms Including Cough in Chronic Obstructive Pulmonary Disease: A Phase 4, Double-Blind, Placebo-controlled, Parallel-Group Study
2019 · Jaclyn A. Smith, Lorcan McGarvey, et al. · American Journal of Respiratory and Critical Care Medicine · 10
Efficacy, safety, and tolerability of once‐daily abediterol in patients with stable, persistent asthma: a Phase II , randomized, 7‐day, crossover study
2017 · Jutta Beier, Rainard Fuhr, et al. · Pharmacology Research & Perspectives · 10
PDF
Single Doses Of LAS100977, A Novel Long Acting ²2-agonist, Show High Activity And Long Duration In Healthy Subjects
2010 · Wolfgang Timmer, Èric Massana, et al. · American Journal of Respiratory and Critical Care Medicine · 10
Long-Term Evaluation of the Effects of Aclidinium Bromide on Major Adverse Cardiovascular Events and COPD Exacerbations in Patients with Moderate to Very Severe COPD: Rationale and Design of the ASCENT COPD Study
2017 · Robert A. Wise, Kenneth R. Chapman, et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · 9
PDF
Efficacy of aclidinium/formoterol fixed-dose combination versus salmeterol/fluticasone in COPD
2015 · Claus Vogelmeier, Pier Luigi Paggiaro, et al. · European Respiratory Journal · 7
Efficacy And Safety Of Single Inhaled Doses Of LAS100977, A Novel Long Acting ²2-agonist In Patients With Persistent Asthma
2010 · Jutta Beier, Rainard Fuhr, et al. · American Journal of Respiratory and Critical Care Medicine · 7
Efficacy and safety of abediterol (LAS100977) in patients with COPD: Phase II, randomised, crossover study
2013 · Jutta Beier, Helena Pujol, et al. · European Respiratory Journal · 6
Aclidinium bromide improves symptoms and sleep quality in COPD: a pilot study
2017 · Helgo Magnussen, Michael Arzt, et al. · European Respiratory Journal · 5
PDF
Navafenterol (AZD8871) in healthy volunteers: safety, tolerability and pharmacokinetics of multiple ascending doses of this novel inhaled, long-acting, dual-pharmacology bronchodilator, in two phase I, randomised, single-blind, placebo-controlled studies
2020 · Victor Balaguer, Muna Albayaty, et al. · Respiratory Research · 4
PDF
A randomized placebo and active controlled trial of AZD8871 a novel dual acting bronchodilator in COPD patients
2017 · Dave Singh, Carol Astbury, et al. · European Respiratory Journal · 4
Abediterol in stable asthma:efficacy, safety and tolerability results from a Phase II, randomised, crossover study
2014 · Jutta Beier, Rainard Fuhr, et al. · European Respiratory Journal · 4
Works count: 47
Citation count: 977
H-index: 14
I10-index: 17
Year
Topic
Type